Camlin Fine Sciences Ltd Stock Price Today (NSE: CAMLINFINE)

Camlin Fine Sciences Ltd

140.09+1.62 (+1.17%)
Market Closed

Fundamental Score

...

Camlin Fine Sciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Camlin Fine Sciences Ltd share price today is 140.09, up +1.17% on NSE/BSE as of 17 June 2026. Camlin Fine Sciences Ltd (CAMLINFINE) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 3.05K (Cr). The 52-week high for CAMLINFINE share price is N/A and the 52-week low is 96.21. At a P/E ratio of 189.68x, CAMLINFINE is currently trading above its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of -14.97% and a debt-to-equity ratio of 0.76.

Camlin Fine Sciences Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
140.09
Low
100.25
Volume
31.5L
Change
+14.71%

Camlin Fine Sciences Ltd share price chart: 14.71% return over the past month. 52-week high ₹N/A, 52-week low ₹96.21.

Camlin Fine Sciences Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
120.40122.64118.10118.948.61L (Cr)
126.00126.07118.50119.448.50L (Cr)
130.00131.27125.57126.4512.13L (Cr)
135.06137.20130.99131.999.48L (Cr)
137.05140.00135.49136.2517.91L (Cr)
131.40137.47130.00136.4316.75L (Cr)
132.60134.49129.09130.6411.91L (Cr)
128.90135.30128.00131.6526.86L (Cr)
126.94126.94126.94126.940.00 (Cr)
122.00128.46118.90126.9422.94L (Cr)

Camlin Fine Sciences Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
126.94140.00118.10118.94-6.30%
100.000.000.00126.94+26.94%
141.05147.1796.2196.93-31.28%
138.90192.00136.22147.90+6.48%
148.58166.59135.00145.27-2.23%
163.91169.89141.00148.40-9.46%
195.00201.79148.99164.92-15.43%
196.00211.95179.00195.90-0.05%
200.00235.00191.05195.22-2.39%
280.80280.80193.95203.65-27.48%
314.70319.00240.00267.45-15.01%
312.00333.30286.05313.80+0.58%

AI Research Briefing

Powered by Gemini · 2026-04-08

Earnings collapse, high debt, and integration risks make Camlin Fine Sciences a value trap.

Research Confidence
8.0/10High
DEBT TRAP TURNAROUNDBreakdown: 1M -17.2%, 3M -23.23%, 6M -37.88%Expensive: P/E is 189.68x vs. industry P/E of 29.2x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Camlin Fine Sciences (CAMLINFINE) faces headwinds. The stock hit a 52-week low of on March 30, 2026. Q3 FY26 results show a YoY net profit decline of 395.99% to ₹-37.10 crore. Revenue decreased QoQ by 0.57% but increased YoY by 6.07% to Operating profit also tanked, decreasing QoQ by 120.45% to ₹-4.93 crore. The company received a GST demand order of plus a matching penalty. CFSL is seeking shareholder approval to increase authorized share capital from to

CORE STORY (THE REAL GAME)

Camlin Fine Sciences is a specialty chemical company attempting a turnaround via strategic acquisitions (Vinpai) and expansion into high-growth areas like natural ingredients. Market sentiment is negative, with concerns around profitability and debt.

Why Now
  • Q3 FY26 results show significant profit decline
  • Stock hit a 52-week low recently
  • GST demand order and promoter pledging raise concerns
Potential Catalysts
  • Successful integration of Vinpai
  • Recovery in vanillin demand
  • Debt reduction and improved interest coverage
Key Risks
  • Small-cap: liquidity risk
  • High debt-to-equity ratio: 0.76
  • Promoter pledging: 10.84%
Institutional Activity

FII decreased holdings by 0.77%, while DII increased by 1.34%. Promoter pledged ₹15.3 Cr shares.

Macro Context

The Indian specialty chemicals sector is projected to grow, but Camlin Fine Sciences faces company-specific challenges.

Cash Flow Quality

No: Free Cash Flow 5Y is ₹-64.04 Cr

3–6 Month Outlook

Near-term outlook is negative due to weak earnings and integration challenges. A successful turnaround depends on Vinpai synergies and debt reduction.

Primary Thesis Risk

Inability to integrate Vinpai and manage debt will lead to collapse.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

-14.97%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

11.03%

Returns generated on total capital deployed

Good

Oper. Profit Margin (5Y Avg)

12.80%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Camlin Fine Sciences Ltd Valuation Check

Poor

Price to Earnings (P/E)

189.68x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

29.20x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

49.08%

% shares held by company founders/management

Poor

FII Holding

2.11%

% shares held by foreign institutional investors

Average

DII Holding

5.48%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

10.84%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-115.76%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

10.19%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

9.70%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.76x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.48x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-64.04 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Camlin Fine Sciences Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of CAMLINFINE across key market metrics for learning purposes.

Positive Indicators

0 factors identified

No significant strengths identified in current analysis.

Risk Factors

7 factors identified

Below-Average Return on Equity (-14.97%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Premium Valuation Risk (P/E: 189.68x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-115.76%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Interest Coverage (1.48x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-64.04 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 7.59%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Camlin Fine Sciences Ltd vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Camlin Fine Sciences Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
4.6/100
140
₹3049.60
189.7
Average
-14.97%
Poor
11.03%
Average
0.8
Good
9.70%
Good
0.00%
60.4/100
1481
₹149466.57
66.6
Average
23.05%
Excellent
29.84%
Excellent
0.1
Excellent
12.63%
Good
12.49%
Good
0.68%
51.5/100
3682
₹37241.99
54.8
Average
8.29%
Poor
9.89%
Poor
0.2
Excellent
21.05%
Excellent
12.69%
Good
0.09%
40.6/100
7245
₹29462.02
66.3
Average
11.52%
Average
11.68%
Average
0.3
Excellent
-6.59%
Poor
17.22%
Excellent
0.21%
40.2/100
1715
₹21083.64
39.7
Average
13.36%
Average
16.28%
Good
0.2
Excellent
2.02%
Average
14.38%
Good
0.49%
52/100
3430
₹17807.40
46.3
Average
13.73%
Average
18.02%
Good
0.0
Excellent
57.98%
Excellent
14.83%
Good
0.49%
Atul Ltd...
ATUL500027
50.5/100
7003
₹17066.13
31.5
Average
9.10%
Poor
12.81%
Average
0.0
Excellent
-5.82%
Poor
6.41%
Good
0.43%
57.2/100
1325
₹16256.72
35.0
Average
15.75%
Good
20.61%
Excellent
0.0
Excellent
4.46%
Average
16.92%
Excellent
0.48%
37.5/100
1368
₹14036.52
92.8
Average
3.32%
Poor
7.33%
Poor
0.4
Excellent
11.97%
Good
22.13%
Excellent
0.06%
41.9/100
501
₹13796.68
51.3
Average
6.03%
Poor
6.32%
Poor
0.7
Good
-9.09%
Poor
11.68%
Good
0.26%
60.5/100
4677
₹13359.76
33.4
Average
19.47%
Good
26.39%
Excellent
0.0
Excellent
20.04%
Excellent
16.93%
Excellent
0.25%

Camlin Fine Sciences Ltd PE Ratio History

Historical price-to-earnings ratio for CAMLINFINE — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20233.33₹135.8040.8x
FY 20224.43₹160.1036.2x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Camlin Fine Sciences Ltd Dividend History

Annual cash dividends paid by CAMLINFINE — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 202428.13 Cr
FY 202313.85 Cr
FY 20220.71 Cr
FY 20215.42 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Camlin Fine Sciences Ltd Quarterly Performance

Latest quarterly metrics for CAMLINFINE — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

10.19%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-115.76%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

9.70%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Camlin Fine Sciences Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for CAMLINFINE — calculated from daily price history

48RSI 14
Neutral — RSI 48

Momentum is balanced — neither overbought nor oversold.

SMA 50
NaN
▼ Price below SMA 50 — Short-term bearish
SMA 200
NaN
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
2601K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Camlin Fine Sciences Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Camlin Fine Sciences Ltd (CAMLINFINE) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Camlin Fine Sciences Ltd

About CAMLINFINE (Camlin Fine Sciences Ltd)

Camlin Fine Sciences Ltd is a dynamic force in the specialty chemicals sector, dedicated to crafting and distributing solutions that enhance the quality and longevity of products w...orldwide. With a focus on innovation and sustainability, the company develops high-performance ingredients and additive blends for diverse applications. From extending the shelf life of consumables to enriching the sensory appeal of everyday items, Camlin Fine Sciences consistently pushes the boundaries of chemical science. With a commitment to research and development, the company aims to create novel and environmentally responsible solutions that meet the ever-evolving needs of its global customer base. The company’s portfolio is built upon a foundation of robust research and development, leading to a range of advanced chemical solutions. They deliver shelf-life enhancement solutions such as TBHQ, BHA, BHT, and ASP. Camlin Fine Sciences serves various industries, offering customized solutions that address specific challenges and requirements. Furthermore, they are leaders in aroma ingredients, including vanillin and ethyl vanillin, and their commitment to quality and consistency has earned them a reputation as a trusted partner for manufacturers seeking to elevate their products and extend shelf life. Driven by a global perspective, Camlin Fine Sciences operates with a dedication to excellence and ethical business practices. The company understands the importance of regulatory compliance and strives to meet the highest standards of safety and environmental stewardship. With a network that spans across continents, Camlin Fine Sciences is committed to serving customers wherever they operate, providing reliable access to its innovative chemical solutions. With a long-term vision and a focus on sustainable growth, Camlin Fine Sciences is well-positioned to remain a leading player in the specialty chemicals industry.

Company Details

Symbol:CAMLINFINE
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Ashish Subhash Dandekar
Chairman & MD
Mr. Nirmal Vinod Momaya
MD & Director
Mr. Arjun Sudhakar Dukane
Executive Director of Technical & Executive Director

Corporate Events

Recent
Ex-Dividend Date

CAMLINFINE Share Price: Frequently Asked Questions

What is the current share price of Camlin Fine Sciences Ltd?

Camlin Fine Sciences Ltd (CAMLINFINE) trades at ₹140.09 on NSE and BSE. Market cap ₹3.05K (Cr). Educational data only.

What is the P/E ratio of Camlin Fine Sciences Ltd?

Camlin Fine Sciences Ltd has a P/E of 189.68x vs industry average 29.20x.

What is the Bull Run score for Camlin Fine Sciences Ltd?

Camlin Fine Sciences Ltd has a Bull Run score of 4.6/100 based on 25+ financial parameters.

Does Camlin Fine Sciences Ltd pay dividends?

Camlin Fine Sciences Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Camlin Fine Sciences Ltd?

Camlin Fine Sciences Ltd has ROE of -14.97%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Camlin Fine Sciences Ltd?

Camlin Fine Sciences Ltd has debt-to-equity of 0.76.

Is Camlin Fine Sciences Ltd a good investment?

Bull Run gives Camlin Fine Sciences Ltd a score of 4.6/100. This is not investment advice — consult a SEBI-registered advisor.